Op-Ed Defends Relationships Between Pharmaceutical Companies, Researchers
Main Category: Pharma Industry / Biotech IndustryArticle Date: 13 Apr 2009 - 1:00 PDT
| Patient / Public: | ![]() |
4 (2 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
Critics who label relationships between university researchers and medical companies "as a morality play in which noble academics struggle to resist the dark, corrupting influence of industry" fail to realize that the "goal of medical research is not to publish papers, but to develop new treatments for people suffering from disease," management consultant David Shaywitz and Harvard University professor and Manhattan Institute Fellow Thomas Stossel write in a Wall Street Journal opinion piece. They continue, "After years of extensive public investment of billions of dollars in medical research, we have generated thousands of scientific papers, but few important new treatments for dreadful conditions."
They add that while "we have won some important battles" -- such as developments in statins and blood pressure medicines and HIV treatments -- "behind these spectacular achievements is an arduous, expensive and underappreciated journey, occurring largely in industry." The piece continues, "Given the vital role of medical products companies and the magnitude of their challenges, one might imagine that this industry would be admired," but "this enlightened view of industry is not widespread," as a "coterie of prominent critics we have previously dubbed as 'pharmascolds' ... routinely vilify the medical products industry and portray academics working with it as traitors and sellouts."
Shaywitz and Stossel write, "For the sake of the many patients whose diseases require innovative treatments -- and for the medical philanthropists determined to make it happen -- it's time for the leaders of the medical products industry to take pride in their purpose and start fighting back" (Shaywitz/Stossel, Wall Street Journal, 4/8).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/145800.php>
APA
http://www.medicalnewstoday.com/releases/145800.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




